secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
CIK:        0001742927
Form:       8-K
Filed at:   2024-05-29T23:59:59+00:00
Accession:  0001437749-24-018540
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Reviva announces $3M registered direct offering of 1.9M shares and warrants at $1.58/unit
--------------------------------------------------------------------------------

- Sold 1,898,734 shares and warrants at $1.58/unit; warrants exercisable at $1.455 for 5 years.
- Net proceeds ~$3.0M; funds Phase 3 RECOVER-2 trial and working capital.
- Existing Nov 2023 warrants (1,365,854 shares, $5.00 exercise) amended to $1.455, extended 5 years.
- H.C. Wainwright placement agent; cash fee 6% of gross proceeds.
- Closing expected May 29, 2024, subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1742927/000143774924018540/0001437749-24-018540-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1742927/000143774924018540/rvph20240528_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-018540

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer